Pantherna Therapeutics to present at the Creative Transformative Medicine Europe User Group Meeting

Dr. Oliver Keil (CTO), Dr. Volker Fehring (Head of Formulation) and Dr. Klaus Giese (CEO) will attend the Creative Transformative Medicine Europe User Group Meeting to be held at the University of Strathclyde, Glasgow, on Wednesday, October 9, 2019. Dr. Klaus Giese will present Pantherna’s delivery technology for mRNA therapeutics.